[1] |
Stein PD, Beemath A, Meyers FA,et al.Incidence of venous thromboembolism in patients hospitalized with cancer[J]. Am J Med, 2006, 119(1):60-68.DOI: 10.1016/j.amjmed.2005.06.058.
|
[2] |
Okabe T, Nozaki T, Aida N,et al.MR imaging findings in some rare neurological complications of paediatric cancer[J]. Insights Imaging, 2018, 9(3):313-324.DOI: 10.1007/s13244-018-0628-z.
|
[3] |
Finelli PF, Nouh A.Three-territory DWI acute infarcts:diagnostic value in cancer-associated hypercoagulation stroke (Trousseau syndrome)[J]. AJNR Am J Neuroradiol, 2016, 37(11):2033-2036.DOI: 10.3174/ajnr.A4846.
|
[4] |
Chen W, He Y, Su Y.Multifocal cerebral infarction as the first manifestation of occult malignancy:case series of trousseau′s syndrome and literature review[J]. Brain Circ, 2018, 4(2):65-72.DOI: 10.4103/bc.bc_1_18.
|
[5] |
Radulescu VC, D′Orazio JA.Venous thromboembolic disease in children and adolescents[J]. Adv Exp Med Bio, 2017(906):149-165.DOI: 10.1007/5584_2016_113.
|
[6] |
|
[7] |
Thachil J, Falanga A, Levi M,et al.Management of cancer-associated disseminated intravascular coagulation:guidance from the SSC of the ISTH[J]. J Thromb Haemost, 2015, 13(4):671-675.DOI: 10.1111/jth.12838.
|
[8] |
|
[9] |
|
[10] |
Tsushima M, Metoki N, Hagii J, et al. D-dimer and C-reactive protein as potential biomarkers for diagnosis of Trousseau′s syndrome in patients with cerebral embolism[J]. J Stroke Cerebrovasc Dis, 2020, 29(2):104534.DOI: 10.1016/j.jstrokecerebrovasdis.2019.104534.
|
[11] |
Ito S, Kikuchi K, Ueda A,et al.Changes in serial D-Dimer levels predict the prognoses of Trousseau′s syndrome patients[J]. Front Neurol, 2018(9):528.DOI: 10.3389/fneur.2018.00528.
|
[12] |
Zhang P, Wang C, Wu J,et al.A systematic review of the predictive value of plasma D-dimer levels for predicting stroke outcome[J]. Front Neurol, 2021(12):693524.DOI: 10.3389/fneur.2021.693524.
|
[13] |
Levine M, Hirsh J, Gent M,et al.Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer[J]. Lancet, 1994, 343(8902):886-889.DOI: 10.1016/s0140-6736(94)90008-6.
|
[14] |
el-Shami K, Griffiths E, Streiff M.Nonbacterial thrombotic endocarditis in cancer patients:pathogenesis,diagnosis,and treatment[J]. Oncologist, 2007, 12(5):518-523.DOI: 10.1634/theoncologist.12-5-518.
|
[15] |
Farge D, Frere C, Connors JM,et al.2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer[J]. Lancet Oncol, 2019, 20(10):e566-e581.DOI: 10.1016/S1470-2045(19)30336-5.
|
[16] |
Tsoukalas N, Tsapakidis K, Galanopoulos M,et al.Real world data regarding the management of cancer-associated thrombosis[J]. Curr Opin Oncol, 2020, 32(4):289-294.DOI: 10.1097/CCO.0000000000000646.
|
[17] |
|
[18] |
Pan KH, Kim J, Chung JW,et al.Significance of D-dimer in acute ischemic stroke patients with large vessel occlusion accompanied by active cancer[J]. Front Neurol, 2022, 3(13):843871.DOI: 10.3389/fneur.2022.843871.
|
[19] |
Kwon HM, Kang BS, Yoon BW.Stroke as the first manifestation of concealed cancer[J]. J Neurol Sci, 2007, 258(1-2):80-83.DOI: 10.1016/j.jns.2007.02.035.
|